Citius Pharmaceuticals, Inc. Cash Flow Statement
CTXR|3 years of annual SEC 10-K data (FY2011-FY2013)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 3 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$1M
FY2013
Free Cash Flow
N/A
FY2013
Capital Expenditures
N/A
Cash used for long-term assets
Dividends Paid
N/A
FY2013
Citius Pharmaceuticals, Inc. used $1M in operating cash flow in FY2013.
Based on SEC 10-K filings.
Key Data Points
- Piotroski F-Score: 2/9 criteria passed
- Negative shareholders equity: Liabilities exceed assets
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2013 | FY2012 | FY2011 |
|---|---|---|---|
| Net Income | -$1.3M | -$22.0K | -$26.3K |
| Operating Cash Flow | -$1.1M | -$20.3K | -$20.8K |